Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., participated in a plenary presentation on the changing nature of health-related evidence at the AcademyHealth Annual Research Meeting. He contributed to the discussion about how the addition of healthcare data and artificial intelligence is shifting the generation and application of evidence to improve health and healthcare.  

The speakers examined where real-world evidence meets health services research and discussed how data can be made relevant, contextualized and fit for the purposes of decision making in multiple contexts. They hope to see faster innovation that leads to continued evidence generation and benefits for patients.  

Some of the subjects covered included the use of synthetic data and the need to continuously monitor and evaluate AI algorithms, a process Dr. Embi coined as “algorithmovigilance.” 

Dr. Embí is an internationally recognized leader in the field of clinical and translational research informatics. Artificial intelligence and learning health systems are two of his areas of expertise; both help to turn real-world data into real-world evidence and apply it to improve healthcare.  

Also on the panel were Tanish Carino, PhD of Alexion; Carolyn Magill, MBS of Aetion and Amy Abernathy, M.D., PhD, formerly of the U.S. Food and Drug Administration.  

At the AcademyHealth Annual Research Meeting, health services researchers, policy analysts, clinicians and community members who use evidence and data to transform health and healthcare convene to connect, reflect and learn. 2021’s event was virtual due to the pandemic.  

As part of the conference, Regenstrief and Indiana University Richard M. Fairbanks School of Public Health at IUPUI Research Scientist Nir Menachemi, PhD, MPH, was honored with the Health Services Research Impact Award, in part for his leadership of the first and largest statewide random sample testing study for COVID-19, which generated breakthrough knowledge about the virus.  

About Peter Embí, M.D., M.S.

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S. is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health.  

Related Influence

Sep 10, 2021 • Influence
Regenstrief CEO co-authors AHRQ blog calling for action to achieve health equity
Regenstrief Institute President and Chief Executive Officer Peter Embí, M.D., M.S., joined with other health leaders to call for action to address health disparities in the United States.   Dr. Embí and fellow members of the Agency for Healthcare Research and Quality (AHRQ)’s National Advisory Council wrote a blog about strategies to make meaningful changes to improve health equity.…
Continue Reading >
Sep 09, 2021 • Influence
Regenstrief research scientist: Possibility of COVID, flu “twindemic” very real
Regenstrief Institute Director of Public Health Informatics Brian Dixon, PhD, MPA, is one of many public health experts who are concerned about severe COVID-19 infections stacking on top of regular flu hospitalizations.   "The possibility of a 'twindemic' is very real, especially this year," he said. Last year there were very few flu cases, but experts attribute that to mask mandates, social…
Continue Reading >